Skip to main content
. 2021 Jun 15;112(8):3255–3265. doi: 10.1111/cas.14980

FIGURE 3.

FIGURE 3

Treatment duration and time to response among patients in the pembrolizumab plus pemetrexed‐platinum group. Light green bars indicate the months of follow up. AE, adverse event; CR, complete response; PD, progressive disease; PR, partial response